Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Douglas Middleton Dahl, M.D.

Co-Author

This page shows the publications co-authored by Douglas Dahl and Chin-Lee Wu.
Connection Strength

3.978
  1. Transperineal multiparametric magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy combined with standard template improves perineural invasion detection. Hum Pathol. 2021 Nov; 117:101-107.
    View in: PubMed
    Score: 0.983
  2. Case 36-2018: A 29-Year-Old Man with an Incidentally Discovered Renal Mass. N Engl J Med. 2018 11 22; 379(21):2064-2072.
    View in: PubMed
    Score: 0.812
  3. Pathologic outcome of laparoscopic and open radical prostatectomy. Urology. 2006 Dec; 68(6):1253-6.
    View in: PubMed
    Score: 0.354
  4. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis. Scand J Urol. 2019 Oct; 53(5):287-294.
    View in: PubMed
    Score: 0.213
  5. Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy. Int Urol Nephrol. 2019 Sep; 51(9):1527-1535.
    View in: PubMed
    Score: 0.211
  6. Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome. Clin Genitourin Cancer. 2019 Feb; 17(1):e44-e52.
    View in: PubMed
    Score: 0.200
  7. Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma. Biomed Res Int. 2015; 2015:891045.
    View in: PubMed
    Score: 0.162
  8. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma. Clin Genitourin Cancer. 2015 Oct; 13(5):e353-60.
    View in: PubMed
    Score: 0.159
  9. Midterm oncological outcomes of laparoscopic vs open radical prostatectomy (RP). BJU Int. 2013 Jul; 112(2):190-7.
    View in: PubMed
    Score: 0.138
  10. A close surgical margin after radical prostatectomy is an independent predictor of recurrence. J Urol. 2012 Jul; 188(1):91-7.
    View in: PubMed
    Score: 0.129
  11. Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level. N Engl J Med. 2012 Mar 22; 366(12):1143-50.
    View in: PubMed
    Score: 0.128
  12. Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol. 2013 Oct; 31(7):1033-7.
    View in: PubMed
    Score: 0.126
  13. Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer. N Engl J Med. 2011 Feb 17; 364(7):667-75.
    View in: PubMed
    Score: 0.118
  14. A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524). Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):995-1001.
    View in: PubMed
    Score: 0.089
  15. An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer. Cancer Discov. 2018 03; 8(3):288-303.
    View in: PubMed
    Score: 0.048
  16. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science. 2015 Sep 18; 349(6254):1351-6.
    View in: PubMed
    Score: 0.041
  17. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol. 2015 Sep; 33(9):383.e9-16.
    View in: PubMed
    Score: 0.040
  18. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med. 2010 Mar 31; 2(25):25ra23.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.